BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33221275)

  • 1. Inhibition of proliferation-linked signaling cascades with atractylenolide I reduces myofibroblastic phenotype and renal fibrosis.
    Guo Y; Xiao Y; Zhu H; Guo H; Zhou Y; Shentu Y; Zheng C; Chen C; Bai Y
    Biochem Pharmacol; 2021 Jan; 183():114344. PubMed ID: 33221275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol suppresses the myofibroblastic phenotype and fibrosis formation in kidneys via proliferation-related signalling pathways.
    Zhang X; Lu H; Xie S; Wu C; Guo Y; Xiao Y; Zheng S; Zhu H; Zhang Y; Bai Y
    Br J Pharmacol; 2019 Dec; 176(24):4745-4759. PubMed ID: 31454852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial and interstitial Notch1 activity contributes to the myofibroblastic phenotype and fibrosis.
    Hong W; Zhang G; Lu H; Guo Y; Zheng S; Zhu H; Xiao Y; Papa APD; Wu C; Sun L; Chen B; Bai Y
    Cell Commun Signal; 2019 Nov; 17(1):145. PubMed ID: 31718671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3,3'-Diindolylmethane ameliorates renal fibrosis through the inhibition of renal fibroblast activation in vivo and in vitro.
    Xia ZE; Xi JL; Shi L
    Ren Fail; 2018 Nov; 40(1):447-454. PubMed ID: 30101622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective delivery of IFN-γ to renal interstitial myofibroblasts: a novel strategy for the treatment of renal fibrosis.
    Poosti F; Bansal R; Yazdani S; Prakash J; Post E; Klok P; van den Born J; de Borst MH; van Goor H; Poelstra K; Hillebrands JL
    FASEB J; 2015 Mar; 29(3):1029-42. PubMed ID: 25466892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of spleen tyrosine kinase (syk) suppresses renal fibrosis through anti-inflammatory effects and down regulation of the MAPK-p38 pathway.
    Chen KH; Hsu HH; Yang HY; Tian YC; Ko YC; Yang CW; Hung CC
    Int J Biochem Cell Biol; 2016 May; 74():135-44. PubMed ID: 26948651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic activity of the histone deacetylase inhibitor SB939 on renal fibrosis.
    Kang SW; Lee SM; Kim JY; Kim SY; Kim YH; Kim TH; Kang MS; Jang WH; Seo SK
    Int Immunopharmacol; 2017 Jan; 42():25-31. PubMed ID: 27855304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 signaling attenuates epithelial-to-mesenchymal transition and renal interstitial fibrosis via PI3K/Akt signaling pathways.
    Wang J; Zhu H; Huang L; Zhu X; Sha J; Li G; Ma G; Zhang W; Gu M; Guo Y
    Exp Mol Pathol; 2019 Dec; 111():104296. PubMed ID: 31449784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WISP3 prevents fibroblast-myofibroblast transdifferentiation in NRK-49F cells.
    Yi Y; Ma J; Jianrao L; Wang H; Zhao Y
    Biomed Pharmacother; 2018 Mar; 99():306-312. PubMed ID: 29353205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis.
    Zhang Y; Zou J; Tolbert E; Zhao TC; Bayliss G; Zhuang S
    FASEB J; 2020 Jun; 34(6):7295-7310. PubMed ID: 32281211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trichostatin A ameliorates renal tubulointerstitial fibrosis through modulation of the JNK-dependent Notch-2 signaling pathway.
    Tung CW; Hsu YC; Cai CJ; Shih YH; Wang CJ; Chang PJ; Lin CL
    Sci Rep; 2017 Nov; 7(1):14495. PubMed ID: 29101337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quercetin inhibits kidney fibrosis and the epithelial to mesenchymal transition of the renal tubular system involving suppression of the Sonic Hedgehog signaling pathway.
    Liu X; Sun N; Mo N; Lu S; Song E; Ren C; Li Z
    Food Funct; 2019 Jun; 10(6):3782-3797. PubMed ID: 31180394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway.
    Kim D; Lee AS; Jung YJ; Yang KH; Lee S; Park SK; Kim W; Kang KP
    Nephrol Dial Transplant; 2014 Nov; 29(11):2043-53. PubMed ID: 25031017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Bromopyruvate decreased kidney fibrosis and fibroblast activation by suppressing aerobic glycolysis in unilateral ureteral obstruction mice model.
    Yu H; Zhu J; Chang L; Liang C; Li X; Wang W
    Life Sci; 2021 May; 272():119206. PubMed ID: 33577854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor signals regulate transforming growth factor-β-induced endothelial-to-myofibroblast transition of tumor endothelial cells via Elk1.
    Akatsu Y; Takahashi N; Yoshimatsu Y; Kimuro S; Muramatsu T; Katsura A; Maishi N; Suzuki HI; Inazawa J; Hida K; Miyazono K; Watabe T
    Mol Oncol; 2019 Aug; 13(8):1706-1724. PubMed ID: 31094056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid signaling through its receptor initiates profibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor.
    Sakai N; Chun J; Duffield JS; Lagares D; Wada T; Luster AD; Tager AM
    Kidney Int; 2017 Mar; 91(3):628-641. PubMed ID: 27927603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation.
    Chen W; Yuan H; Cao W; Wang T; Chen W; Yu H; Fu Y; Jiang B; Zhou H; Guo H; Zhao X
    Theranostics; 2019; 9(14):3980-3991. PubMed ID: 31281526
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
    Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
    Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
    Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
    Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.